Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (351)

21

HAWK and HARRIER : Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration

enthalten in: Ophthalmology | 2020

von Dugel, P. | Koh, A. | Ogura, Y. | +8

CommentIn: Ophthalmology. 2019 Dec;126(12):e95-e96. - PMID 31759509

22

Re : Dugel et al: HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration (Ophthalmology. 2019 Apr 12 [Epub ahead of print])

enthalten in: Ophthalmology | 2019

von Sharma, A. | Kumar, N. | Bandello, F.

CommentOn: Ophthalmology. 2020 Jan;127(1):72-84. - PMID 30986442

23

enthalten in: Ophthalmology | 2019

von Dugel, P. | Koh, A. | Ogura, Y. | +8

CommentOn: Ophthalmology. 2020 Jan;127(1):72-84. - PMID 30986442

24

Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU): : The Phase 2 SATURN Study

enthalten in: Ophthalmology | 2019

von Heissigerová, J. | Callanan, D. | de Smet, M. | +17

25

Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration : A Randomized Trial

enthalten in: Ophthalmology | 2017

von Dugel, P. | Jaffe, G. | Sallstig, P. | +4

26

Metastatic Lung Adenocarcinoma

enthalten in: Ophthalmology | 2017

von Kolomeyer, A. | Brucker, A. | O'Brien, J.

27

Re : Boyer et al.: Outcomes with as-needed ranibizumab after initial monthly therapy: long-term outcomes of the phase III RIDE and RISE trials (Ophthalmology 2015;122:2504-13)

enthalten in: Ophthalmology | 2016

von Takkar, B. | Azad, S.

CommentOn: Ophthalmology. 2015 Dec;122(12):2504-13.e1. - PMID 26452713

28

Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration : A Randomized Controlled Study

enthalten in: Ophthalmology | 2016

von Holz, F. | Dugel, P. | Weissgerber, G. | +10

29

Re : Sophie et al.: Predictors of functional and anatomic outcomes in patients with diabetic macular edema treated with ranibizumab (Ophthalmology 2015;122:1395-401)

enthalten in: Ophthalmology | 2016

von Shukla, D.

CommentOn: Ophthalmology. 2015 Jul;122(7):1395-401. - PMID 25870079

30

enthalten in: Ophthalmology | 2016

von Sophie, R. | Lu, N. | Campochiaro, P.

CommentOn: Ophthalmology. 2015 Jul;122(7):1395-401. - PMID 25870079